Cardiovascular and venous thromboembolism risks in cancer patients treated with immune checkpoint inhibitors compared to non-users- a multi-center retrospective study.

Jian-Rong PengJason Chia-Hsun HsiehChih-Hao ChangChi ChuangYu-Ching WangTzu-Yang ChenHung-Chi SuHsin-Fu Lee

Published in: Cardio-oncology (London, England) (2024)

ICIs do not significantly elevate the risk of cardiovascular events in cancer patients and may lower the stroke risk, underscoring the need for additional prospective studies to clarify these findings.

Keyphrases

cardiovascular events
venous thromboembolism
coronary artery disease
papillary thyroid
cardiovascular disease
atrial fibrillation
direct oral anticoagulants
squamous cell
lymph node metastasis
case control
type diabetes
squamous cell carcinoma
young adults
childhood cancer
risk assessment